Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Population attributable fractions and joint effects of key risk factors for multiple sclerosisIaf van der Mei, R M Lucas, B V Taylor, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2001
The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhoodK Elliott, E Fitzpatrick, D Hill, et al.
Neurology|October 26, 2011
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosisM S Stein, Y Liu, O M Gray, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2013
GFI1B mutation causes a bleeding disorder with abnormal platelet functionW S Stevenson, M-C Morel-Kopp, Q Chen, et al.
Clinical Genetics|February 6, 2010
Variable hearing impairment in a DFNB2 family with a novel MYO7A missense mutationM S Hildebrand, N P Thorne, C J Bromhead, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune FunctionR M Lucas, A-L Ponsonby, A J McMichael, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 8, 2013
What is the optimal number of treatment sessions of vestibular rehabilitation?M Rossi-Izquierdo, S Santos-Pérez, J P Rubio-Rodríguez, et al.
Molecular Psychiatry|January 4, 2012
Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levelsJ A Duce, S Ayton, A A Miller, et al.
Neurology|February 9, 2011
Sun exposure and vitamin D are independent risk factors for CNS demyelinationR M Lucas, A-L Ponsonby, K Dear, et al.
Pageof 18